LFVN Lifevantage PE ratio, current and historical analysis
The PE ratio for Lifevantage stock stands at 25.67 as of Mar 7, 2025. The calculation is based on the latest EPS of $0.6 and the stock price of $15.4 per share. A decrease of 9% has been observed in the PE ratio compared to its average of 28.3 of the past four quarters.
LFVN PE ratio history
Over the last ten years, the average PE ratio of Lifevantage has been 23.64. The current 25.67 price-to-earnings ratio is 9% more than the historical average. Analyzing the last ten years, LFVN's PE ratio reached its highest point in the Sep 2022 quarter at 75, with a price of $3.75 and an EPS of $0.05. The Mar 2022 quarter saw the lowest point at 6.7, with a price of $4.76 and an EPS of $0.71.
Lifevantage PE ratio by year
Maximum annual increase: 325.17% in 2016
Maximum annual decrease: -59.44% in 2014
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 26.75 | 22.99% | $6.42 | $0.24 |
| 2023 | 21.75 | 19.97% | $4.35 | $0.2 |
| 2022 | 18.13 | 126.91% | $4.35 | $0.24 |
| 2021 | 7.99 | -51.55% | $7.35 | $0.92 |
| 2020 | 16.49 | -32.67% | $13.52 | $0.82 |
| 2019 | 24.49 | 57.59% | $12.98 | $0.53 |
| 2018 | 15.54 | -56.93% | $6.37 | $0.41 |
| 2017 | 36.08 | 16.73% | $4.33 | $0.12 |
| 2016 | 30.91 | 325.17% | $13.6 | $0.44 |
| 2015 | 7.27 | -45.91% | $3.71 | $0.51 |
| 2014 | 13.44 | -59.44% | $10.08 | $0.75 |
| 2013 | 33.14 | 40.54% | $16.24 | $0.49 |
| 2012 | 23.58 | N/A | $19.81 | $0.84 |
| 2011 | N/A | N/A | $10.5 | -$4.83 |
| 2010 | N/A | N/A | $3.57 | -$1.33 |
Lifevantage PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Dec 2024 | 29.22 | -17.76% | $17.53 | $0.6 |
| Sep 2024 | 35.53 | 32.82% | $12.08 | $0.34 |
| Jun 2024 | 26.75 | 23.79% | $6.42 | $0.24 |
| Mar 2024 | 21.61 | -17.17% | $6.05 | $0.28 |
| Dec 2023 | 26.09 | -19.1% | $6 | $0.23 |
| Sep 2023 | 32.25 | 48.28% | $6.45 | $0.2 |
| Jun 2023 | 21.75 | N/A | $4.35 | $0.2 |
| Mar 2023 | N/A | N/A | $3.59 | -$0.05 |
| Dec 2022 | N/A | N/A | $3.72 | -$0.04 |
| Sep 2022 | 75 | 313.68% | $3.75 | $0.05 |
| Jun 2022 | 18.13 | 170.6% | $4.35 | $0.24 |
| Mar 2022 | 6.7 | -21.55% | $4.76 | $0.71 |
| Dec 2021 | 8.54 | 26.14% | $6.32 | $0.74 |
| Sep 2021 | 6.77 | -15.27% | $6.77 | $1 |
| Jun 2021 | 7.99 | -29.1% | $7.35 | $0.92 |
LFVN average PE ratio chart
Currently, LFVN's PE ratio is higher than the 5 and 10-year averages, but it is under its 3-year average.
LFVN PE vs peers
LFVN's PE ratio is above its peer stocks USNA and NATR.
| Stock name | PE ratio | Market cap |
|---|---|---|
| USNA Usana Health Sciences Inc | 11.61 | $628.2M |
| NATR Natures Sunshine Products Inc | 16.56 | $269.19M |
| LFVN Lifevantage Corp | 25.67 | $193.29M |
| OGEN Oragenics Inc | N/A | $3.47M |
| MTEX Mannatech Inc | N/A | $21.9M |
Frequently asked questions
What is Lifevantage's PE ratio?
As of Mar 7, 2025, LFVN stock has a price to earnings ratio of 25.67.
What is the 3-year average PE ratio for Lifevantage (LFVN)?
As an average over the last 3 years, LFVN stock has a PE ratio of 29.3.
What is the 5-year average PE ratio for Lifevantage (LFVN)?
As an average over the last 5 years, LFVN stock has a PE ratio of 21.19.
What is the highest PE ratio for LFVN?
Over the last ten years, the quarterly PE ratio reached its highest level at 75 in the Sep 2022 quarter.
How does the current PE ratio for LFVN compare to its historical average?
LFVN's current price to earnings ratio is 9% above its 10-year historical average.
How is LFVN's PE ratio calculated (Lifevantage PE ratio formula)?
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Mar 7, 2025), Lifevantage's share price is $15.4. The company's earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $0.6. Therefore, Lifevantage's price to earnings ratio for today is 25.67. PE RATIO(25.67) = STOCK PRICE($15.4) / TTM EPS($0.6)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.